Effects of melatonin on uterine contractions in pregnant women
Official title: Testing Effects of Melatonin on Uterine Contractions in Women
Run by Brigham and Women's Hospital · NCT05358834 · Data updated 2026-11-12
This study tests whether taking melatonin can change the frequency of uterine contractions in full-term pregnant women.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | May 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT05358834 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are nulliparous women aged 18 to 35, with a BMI under 36, who are at least 38 weeks pregnant with a single fetus.
✕Probably not a fit
Patients with medical conditions or medications that contraindicate melatonin use or affect uterine contractions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between melatonin levels and uterine contractions in full-term pregnant women. It builds on previous research that explored how melatonin affects the human myometrium and uterine activity. The study will manipulate melatonin levels using exogenous melatonin during different times of the day to observe its effects on uterine contractions. Participants will be monitored to establish a causal link between melatonin and contraction frequency.
Why it matters
Potential benefit: If successful, this study could provide insights into managing uterine contractions during labor, potentially improving outcomes for mothers and infants.
How similar studies have gone: While this approach is based on recent physiological discoveries, it is relatively novel and has not been extensively tested in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * nulliparity, age between 18 and 35, * BMI\<36 pre-pregnancy, * ≥38 weeks of pregnancy with a single fetus at time of study. Exclusion Criteria: * color blind; * prescription drugs affecting sleep, melatonin, and/or circadian rhythms (e.g., beta blockers, non-steroidal anti-inflammatory drugs); * a health or pregnancy related condition that might affect melatonin or uterine contractions; * medical conditions or medications for which melatonin might be contraindicated or there may be a drug interactions (e.g., Central Nervous System depressants/sedatives, Fluvoxamin (Luvox), medications for diabetes, immunosuppressants, anti-coagulants, Nifedipine, Verapamil). Note: We cannot list all possible exclusionary criteria. Dr. Carolina Bibbo (co-I), our Obstetrics Investigator at Brigham and Women's Hospital (BWH), will make final determination of suitability including any safety concerns for each potential participant.
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Elizabeth B Klerman, MD PhD — Mgh
- Study coordinator: Elizabeth B Klerman, MD PhD
- Email: ebklerman@hms.harvard.edu
- Phone: 617-643-2424
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal yoga to help with birth experience and body image
This study tests whether a prenatal yoga program can improve how pregnant women perceive traumatic birth, how they feel about their bodies, and their preferred delivery method.
-
Preventing abdominal stretch marks in expectant mothers with Stratamark
This program will try Stratamark on pregnant women to see if applying it to the abdomen prevents stretch marks during pregnancy and after birth.
-
Oral health knowledge in pregnant women: does a one-time information leaflet help?
A one-time printed leaflet is tested to see if it improves oral health knowledge in pregnant women attending Hospital La Fe.
-
Outpatient induction of labour with a double‑balloon transcervical catheter for low‑risk pregnant women
This trial will test whether starting cervical ripening at home with a double‑balloon catheter is as safe, acceptable, and time‑efficient as staying in hospital for low‑risk pregnant women due for induction of labour.
-
Using placental blood markers to detect fetal stress during labor
This study will test whether levels of placental markers (sFlt-1, PlGF, and their ratio) can help predict which pregnant people (≥32 weeks) may experience fetal distress during labor.
-
How ultrafine particles and micro‑nano plastics affect fetal development
This project will test whether pregnant women’s exposure to ultrafine particulate matter and micro‑nano plastics increases the chance of preterm birth and later non‑communicable diseases in their children.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.